The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Molex, Unilife, Apple, Quiksilver, Oncolytics, Biodel

Mon, 09th Sep 2013 13:13

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 9 (Reuters) - Some U.S. stocks to watch on Monday:

WALL ST TO OPEN HIGHER ON CHINA DATA; SYRIA CURBS GAINS

U.S. stocks were set for a modestly higher open on Monday inthe wake of upbeat economic data from China, though concernsremained about the possibility of a Western strike againstSyria.

S&P 500 futures rose 3.5 points and were above fairvalue, a formula that evaluates pricing by taking into accountinterest rates, dividends and time to expiration on thecontract. Dow Jones industrial average futures gained 26points, and Nasdaq 100 futures added 12.75 points.

** MOLEX INC, Friday close $29.34, up 31 pctpremarket

The maker of electronic connectors and cable assemblyproducts said privately owned energy and chemicals conglomerateKoch Industries would buy it for about $7.2 billion.

** APPLE INC, Friday close $498.22, up 1.5 pctpremarket

Brokerage FBN Securities raised its price target on thecompany's stock to $600 from $575 in anticipation of Applemaking an announcement of its iPhone 5S and iPhone 5C onTuesday. The brokerage said it expected the phones to startshipping on Sept. 20. FBN sees the iPhone 5C as an opportunityfor Apple to be successful in China.

** UNILIFE CORP, Friday close $3.07, up 25 pctpremarket

The medical device maker said it entered into a long-termcontract to supply pre-filled syringes to Sanofi SA for use with Sanofi's thrombosis drug, Lovenox.

In addition to future revenue from the sale of the syringes,Unilife may receive up to $15 million from Sanofi in milestonepayments, with $5 million expected in 2013. The contract periodcan extend up to 2024.

** QUIKSILVER INC, Friday close $6.85, up 3 pctpremarket

Credit Suisse raised its rating on the apparel andaccessories retailer's stock to "outperform" from "neutral,"according to Theflyonthewall.com.

** BROCADE COMMUNICATIONS, Friday close $7.46, up 3pct premarket

Brokerage RBC Capital Markets upgraded the network equipmentmaker's stock to "outperform" from "sector perform" as itexpects strong demand for Brocade's Fiber Channel protocol. Thebrokerage also expects the company to buy back shares andpossibly issue its first ever dividend. RBC raised its pricetarget on the company's stock to $10 from $7. Brocade's FiberChannel protocol based networking products are used to buildstorage area networks.

** SOLARCITY CORP, Friday close $29.61, down 3premarket

The U.S. solar installer, which is backed by Tesla Motors founder Elon Musk, said shareholder Paramount GRHoldings would sell 3.7 million shares of the company. SolarCitysaid last month that it would buy direct-marketing solar companyParamount Solar for about $120 million in a deal intended tohelp cut the cost of acquiring new customers.

** ONCOLYTICS BIOTECH INC, Friday close $2.65, up17 pct premarket

The company said its cancer drug, Reolysin, reduced the sizeof tumors in 92 percent of lung cancer patients in a mid-stagetrial.

** BIODEL INC, Friday close $5.03, up 12 pctpremarket

The pharmaceutical company said on Sunday that preliminarydata showed its fast-acting regular human insulin BIOD-123 metits goal in a mid-stage trial.

** ISIS PHARMACEUTICALS INC, Friday close $27.92,up 7 pct premarket

Biogen Idec Inc has agreed to pay another $100million upfront to the drugmaker as a part of a broadcollaboration to develop new medicines for neurologicaldisorders, the companies said.

** DELTA AIRLINES, Friday close $19.89, up 5 pctpremarket

The U.S. airline will join the S&P 500 index after the closeof trading on Sept. 10, replacing BMC Software, Standard& Poor's said on Friday.

** BLACKBERRY LTD, Friday close $10.84, up 4.3 pctpremarket

The company's largest shareholder, Prem Watsa, has assembledbillions in backing from Canada's biggest pension funds for abid, The Sunday Times reported on Sunday. (http://link.reuters.com/caz82v)

Watsa is the founder and chairman of Fairfax FinancialHoldings Ltd that holds about 10 percent stake in the company.

** SMITHFIELD FOODS INC, Friday close $33.92, up 2pct after market

The U.S. Committee on Foreign Investment has cleared the wayfor Shuanghui International Holdings Ltd's proposed $4.7 billionacquisition of Smithfield Foods, the companiessaid.

** NETAPP INC, Friday close $42.24, up 2.8 pctpremarket

Brokerage UBS Investment Research raised its rating on thedata storage equipment maker's stock to "buy" from "neutral,"according to the website Theflyonthewall.com.

** JOHNSON & JOHNSON, Friday close $87.16, up 1 pctpremarket

The company has launched a sale process for its OrthoClinical Diagnostics unit, which makes blood screening equipmentand laboratory blood tests and could fetch around $5 billion.J&J has asked JPMorgan Chase & Co to run the sale and ispreparing to send detailed financial information in coming weeksto potential buyers.

** VODAFONE PLC, Friday close $32.89

The company may fail to reach the 75 percent threshold ofacceptances from shareholders needed to clinch Germany's largestcable operator Kabel Deutschland, the Financial Timessaid. Vodafone agreed a 7.7 billion euro ($10.13 billion) offerfor Kabel Deutschland in June, a near 40 percent premium toKabel's share price before its interest first emerged.

** SONY CORP, Friday close $21.02, down 2 pct aftermarket

The electronics maker announced the Japanese release of itsPlayStation 4 on Monday as the company braces for a gamingconsole war with Microsoft Corp that could make orbreak the Japanese firm's struggle to return to profit.

** GLAXOSMITHKLINE PLC, Friday close $51.67

Japan's Suntory Beverage & Food Ltd is to buyGlaxoSmithKline's Lucozade and Ribena brands for 1.35 billionpounds ($2.11 billion) to expand into new markets.

** GOOGLE INC, Friday close $879.58

The U.S. government tapped into computer networks ofcompanies including Google and Brazilian state-run oil firmPetroleo Brasileiro SA, according to leaked U.S.documents aired by Globo, Brazil's biggest television network.

** TIME WARNER INC, Friday close $61.45

The entertainment company is planning to transfer its U.S.retirees from company-sponsored health plans and move them toprivate insurance exchanges. According to an August memoobtained by Reuters, the media company will make allocations toa Health Reimbursement Arrangement account for retirees to usetowards the purchase of coverage on an exchange. Previously,Time Warner provided an indirect subsidy through a supplementaryMedicare program. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.